⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SPRY News
ARS Pharmaceuticals, Inc. Common Stock
Shareholders of ARS Pharmaceuticals, Inc. (SPRY): Protect Your Rights Before October 5, 2026 – Contact Levi & Korsinsky
accessnewswire.com
SPRY
SPRY SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ARS Pharmaceuticals Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
SPRY
Levi & Korsinsky Urges ARS Pharmaceuticals (SPRY) Shareholders to Act Before Lead Plaintiff Deadline October 5, 2026
accessnewswire.com
SPRY
Pomerantz LLP Issues Reminder to Shareholders in ARS Pharmaceuticals, Inc. of Class Action – SPRY
accessnewswire.com
SPRY
Levi & Korsinsky Urges ARS Pharmaceuticals, Inc. (SPRY) Shareholders to Act Before Lead Plaintiff Deadline October 5, 2026
accessnewswire.com
SPRY
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SPRY
accessnewswire.com
SPRY
Lost Money on ARS Pharmaceuticals, Inc. (SPRY)? Join Class Action Before October 5, 2026 – Contact Levi & Korsinsky
accessnewswire.com
SPRY
Pomerantz LLP Issues Reminder to Investors in ARS Pharmaceuticals, Inc. of Class Action Lawsuit – SPRY
accessnewswire.com
SPRY
Pomerantz LLP Issues Reminder to Investors in ARS Pharmaceuticals, Inc. of Class Action Lawsuit – SPRY
accessnewswire.com
SPRY
ARS Pharmaceuticals, Inc. (SPRY) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of October 5, 2026 Deadline
accessnewswire.com
SPRY